Syncremedies Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.12 M
as on 27-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 19.64%
(FY 2023)
- Profit -151.39%
(FY 2023)
- Ebitda -80.15%
(FY 2023)
- Net Worth 23.29%
(FY 2023)
- Total Assets 16.95%
(FY 2023)
About Syncremedies Healthcare
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Arjun Rao and Sanjeet Kumar serve as directors at the Company.
- CIN/LLPIN
U74999KA2016PTC094980
- Company No.
094980
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2016
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Syncremedies Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Rao  | Director | 14-Jul-2016 | Current |
Sanjeet Kumar  | Director | 31-May-2019 | Current |
Financial Performance of Syncremedies Healthcare.
Syncremedies Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.64% increase. The company also saw a substantial fall in profitability, with a 151.39% decrease in profit. The company's net worth Soared by an impressive increase of 23.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syncremedies Healthcare?
In 2023, Syncremedies Healthcare had a public holding of 14.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syncremedies Healthcare?
Unlock and access historical data on people associated with Syncremedies Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syncremedies Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncremedies Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
